
November 17, 2022
RegMed Investors’ (RMi) pre-open: following the market outlook and bouncing share pricings
November 16, 2022
RegMed Investors’ (RMi) pre-open: whatever floats your boat or fills your portfolio, short-term moves could defend your positions
November 15, 2022
RegMed Investors’ (RMi) pre-open: Monday’s whiplash leaves share pricing ready to move upward
November 14, 2022
RegMed Investors’ (RMi) pre-open: after an upside ending week
November 11, 2022
RegMed Investors’ (RMi) pre-open: post massive gains, what usually follows is pain
November 10, 2022
RegMed Investors’ (RMi) pre-open: CPI, up +0.4% versus +0.6% estimate
November 9, 2022
RegMed Investors’ (RMi) pre-open: stock futures trade lower as election results are tallied
November 8, 2022
RegMed Investors’ (RMi) pre-open: vote your conscious and your portfolio
November 7, 2022
RegMed Investors’ (RMi) pre-open: the cell and gene therapy sector is stuck in earnings LPS (loss-per-share) season
November 4, 2022
RegMed Investors’ (RMi) pre-open: We need to understand the macro to comprehend the micro re “our” universe of cell and gene therapy companies
November 3, 2022
RegMed Investors’ (RMi) pre-open: gains followed by pain; so, what’s on-tap - earnings
November 2, 2022
RegMed Investors’ (RMi) pre-open: bracing for Fed’s policy decision
November 1, 2022
RegMed Investors’ (RMi) pre-open: the ups, the downs and the uglies i.e., share pricing
October 31, 2022
RegMed Investors’ (RMi) pre-open: final session of October
October 28, 2022
RegMed Investors’ (RMi) pre-open: what’s to deal with beforehand that might hinder sector’s progress in November?
October 27, 2022
RegMed Investors’ (RMi) pre-open: I’m anxious and fearful
October 26, 2022
RegMed Investors’ (RMi) pre-open: electronic trading and algorithmic rules keep sentiment on a leash
October 25, 2022
RegMed Investors’ (RMi) pre-open: exposure to risk never changes
October 24, 2022
RegMed Investors’ (RMi) pre-open: downshift following a volatile week
October 21, 2022
RegMed Investors’ (RMi) pre-open: climbing the ladder of share pricing
October 20, 2022
RegMed Investors’ (RMi) pre-open: weakness
October 19, 2022
RegMed Investors’ (RMi) pre-open: I’d be letting the upsiders run and then fast walk share pricing profits
October 18, 2022
RegMed Investors’ (RMi) pre-open: how many signals are needed to forecast the sector’s move
October 17, 2022
RegMed Investors’ (RMi) pre-open: earnings are the elephant in the room
October 14, 2022
RegMed Investors’ (RMi) pre-open: an absence of certainty in inflation and earnings
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors